RxDoctor Payments Data

Thomas Tadros, MD

Clinical Cardiac Electrophysiology · Boston, MANPI 1043400187

Payments from drug & device makers

What this record shows

9 manufacturers reported payments, led by Medtronic at 28.1% of the total. Reporting peaked in 2024 at $4,477 and has fallen 76.1% since, to $1,071 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MA, where the typical reported total is $10,274.

$11,175in general payments, 2019–2025

Across 91 payments — averaging $122.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Abbott$3K
  • Atricure, Inc.$3K
  • Boston Scientific$790
  • Cardiofocus, Inc.$504
  • Biotronik Inc.$464
  • plus $250 from 3 others
$22,400in research payments, 2019–2025

Across 1 payment — averaging $22,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Impulse Dynamics (USA) Inc.$22K

What the payments were for

  • Travel & lodging$5,95553%
  • Food & beverage$5,22047%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,175 in reported general payments places this provider in the 50th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$228,471
Medicare patients
720
Services billed
1,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban51$39,080
EliquisApixaban56$36,568
Metoprolol Succinate31$656
Amiodarone Hcl25$528

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →